USSTOCK.TODAY
Market Closed
Log in Sign up

Gap emerges between market estimates and guidelines ahead of AbbVie Q3 earnings release

Earnings Whispers ·

ABBV Abbvie Inc
$285.19 +0.14%
View chart & analysis →
  1. 1AbbVie will announce its third-quarter results before the US market opens on October 30.
  2. 2The Street expects revenue of $17.37 billion and earnings per share of $3.76.
  3. 3A revenue increase of approximately 10% for AbbVie compared to last year is projected.

So what's the key point?

AbbVie is scheduled to release its third-quarter results on October 30. Experts expect revenue to increase by about 10% compared to last year.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Invesco Pharmaceutical & Biotech ETF Returns and Volatility Comparison The Motley Fool +1 · 13h agoAbbVie expands sports marketing through partnership with McLaren F1 team Pharmaceutical Technology · 23h agoEli Lilly Stock Split Possibility and Corporate Status Nasdaq +2 · Oct 13
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news